- Report
- May 2024
- 97 Pages
Middle East, Africa
From €2626EUR$2,950USD£2,270GBP
- Report
- May 2024
- 122 Pages
Europe
From €3072EUR$3,450USD£2,655GBP
- Report
- May 2024
- 118 Pages
Asia Pacific
From €3072EUR$3,450USD£2,655GBP
- Report
- May 2024
- 128 Pages
Global
From €2626EUR$2,950USD£2,270GBP
- Report
- May 2024
- 68 Pages
Colombia
From €2003EUR$2,250USD£1,731GBP
- Report
- April 2024
- 185 Pages
Global
From €4006EUR$4,500USD£3,462GBP
- Report
- July 2023
- 220 Pages
Global
€4091EUR$4,595USD£3,536GBP
- Report
- July 2023
- 210 Pages
Global
From €4006EUR$4,500USD£3,462GBP
- Report
- April 2023
- 118 Pages
Global
From €4229EUR$4,750USD£3,655GBP
- Report
- November 2022
- 150 Pages
Global
From €4318EUR$4,850USD£3,732GBP
- Report
- November 2022
- 138 Pages
Global
From €1781EUR$2,000USD£1,539GBP
- Directory
- August 2022
- 1046 Pages
Japan
From €8859EUR$9,950USD£7,656GBP
- Report
- March 2022
- 54 Pages
Global
€1603EUR$1,800USD£1,385GBP
- Report
- January 2024
- 126 Pages
Global
From €3500EUR$4,211USD£3,131GBP
- Report
- October 2024
- 99 Pages
Global
From €3500EUR$4,211USD£3,131GBP
- Report
- September 2024
- 79 Pages
Global
From €3500EUR$4,211USD£3,131GBP
- Report
- August 2024
- 104 Pages
Global
From €3500EUR$4,211USD£3,131GBP
- Report
- February 2024
- 81 Pages
Global
From €3500EUR$4,211USD£3,131GBP
- Report
- January 2024
- 121 Pages
Global
From €3500EUR$4,211USD£3,131GBP
- Report
- November 2023
- 101 Pages
Global
From €3500EUR$4,211USD£3,131GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more